Odyssey Health, Inc. (ODYY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue TTM

0 90K 180K 270K Q4 '15: 257.2K Q1 '16: 118.9K Q2 '16: 18K Q3 '16: 22.5K Q4 '16: 37.5K Q1 '17: 37.5K Q2 '17: 37.5K Q3 '17: 15K Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Gross Profit TTM

0 10K 20K 30K Q4 '15: 28.7K Q1 '16: 14.5K Q2 '16: 2.2K Q3 '16: 13.5K Q4 '16: 17.2K Q1 '17: 17.2K Q2 '17: 17.2K Q3 '17: 3.7K Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q4 '16: -73.6K Q1 '17: -64.8K Q2 '17: -76.1K Q3 '17: -145.4K Q4 '17: -167.6K Q1 '18: -201.2K Q2 '18: -406.9K Q3 '18: -391.9K Q4 '18: -420.4K Q1 '19: -423.3K Q2 '19: -281.4K Q3 '19: -269.1K Q4 '19: -23.6M Q1 '20: -24.8M Q2 '20: -25.3M Q3 '20: -26.1M Q4 '20: -3.8M Q1 '21: -3M Q2 '21: -3.2M Q3 '21: -14.4M Q4 '21: -15.9M Q1 '22: -16.8M Q2 '22: -18.1M Q3 '22: -8.9M Q4 '22: -8.1M Q1 '23: -8.8M Q2 '23: -8.3M Q3 '23: -6.5M Q4 '23: -5.3M Q1 '24: -3.6M Q2 '24: -3.3M Q3 '24: -2.5M Q4 '24: -2.1M Q1 '25: -2.4M Q2 '25: -1.4M Q3 '25: -1.1M Q4 '25: -1M Q1 '26: -744.5K Q2 '26: -769.9K Q3 '26: -938.4K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Net Income TTM

-27M -18M -9M 0 9M 18M 27M Q4 '15: -160.7K Q1 '16: -142.2K Q2 '16: -107.7K Q3 '16: -73.3K Q4 '16: -86.1K Q1 '17: -83K Q2 '17: -98.1K Q3 '17: -169.9K Q4 '17: -197.8K Q1 '18: -239.4K Q2 '18: -455.4K Q3 '18: -449K Q4 '18: -483.1K Q1 '19: -489.2K Q2 '19: -348.4K Q3 '19: -337.6K Q4 '19: -23.4M Q1 '20: -24.8M Q2 '20: -25.3M Q3 '20: -26.2M Q4 '20: -4.3M Q1 '21: -3.6M Q2 '21: -3.9M Q3 '21: -15.3M Q4 '21: -16.9M Q1 '22: -17.8M Q2 '22: -18.6M Q3 '22: -9.3M Q4 '22: -8.4M Q1 '23: -8.9M Q2 '23: -8.9M Q3 '23: -7.1M Q4 '23: -5.9M Q1 '24: -4.3M Q2 '24: 10.6M Q3 '24: 11.1M Q4 '25: -1.7M Q1 '26: -1.2M Q2 '26: -4.6M Q3 '26: -3.6M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '26

Cost of Revenue TTM

0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '20

Operating Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '16: -60.9K Q1 '17: -42.9K Q2 '17: -14.3K Q3 '17: -89K Q4 '17: -116.6K Q1 '18: -146.7K Q2 '18: -225.4K Q3 '18: -133.1K Q4 '18: -146.1K Q1 '19: -132.8K Q2 '19: -71.8K Q3 '19: -98.1K Q4 '19: -104.8K Q1 '20: -301.2K Q2 '20: -400.4K Q3 '20: -397.2K Q4 '20: -649.1K Q1 '21: -737.9K Q2 '21: -949.2K Q3 '21: -2.8M Q4 '21: -3.2M Q1 '22: -4M Q2 '22: -4.1M Q3 '22: -3.3M Q4 '22: -1.5M Q1 '23: -594.2K Q2 '23: -1.1M Q3 '23: -274.7K Q4 '23: -1.5M Q1 '24: -1.2M Q2 '24: -1.3M Q3 '24: -1.3M Q4 '24: -1.2M Q1 '25: -1.4M Q2 '25: -543K Q3 '25: -362.8K Q4 '25: -347.4K Q1 '26: -382.9K Q2 '26: -620.5K Q3 '26: -935K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '15: 114.8M Q2 '15: 114.8M Q3 '15: 114.8M Q1 '16: 114.8M Q2 '16: 114.8M Q3 '16: 114.8M Q1 '17: 114.8M Q2 '17: 114.8M Q3 '17: 114.8M Q1 '18: 14.8M Q2 '18: 116.4M Q3 '18: 119.8M Q1 '19: 61.4M Q2 '19: 64.7M Q3 '19: 68.7M Q1 '20: 87M Q2 '20: 87.1M Q3 '20: 87.2M Q3 '21: 93.4M Q1 '22: 88.1M Q2 '22: 91.6M Q3 '22: 83.9M Q1 '23: 80.9M Q2 '23: 81.8M Q3 '23: 83.2M Q1 '24: 81M Q2 '24: 114.1M Q3 '24: 103.8M Q1 '25: 104.7M Q2 '25: 104.7M Q3 '25: 104.7M Q1 '26: 106M Q2 '26: 107.9M Q3 '26: 186.7M Q1 '16 Q3 '17 Q2 '19 Q3 '21 Q2 '23 Q1 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: 0.00 Q1 '18: 0.00 Q2 '18: 0.00 Q3 '18: 0.00 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: -0.34 Q1 '20: -0.36 Q2 '20: -0.37 Q3 '20: -0.38 Q4 '20: -0.06 Q1 '21: -0.05 Q2 '21: -0.05 Q3 '21: -0.17 Q4 '21: -0.18 Q1 '22: -0.19 Q2 '22: -0.20 Q3 '22: -0.11 Q4 '22: -0.10 Q1 '23: -0.11 Q2 '23: -0.11 Q3 '23: -0.09 Q4 '23: -0.08 Q1 '24: -0.06 Q2 '24: 0.08 Q3 '24: 0.09 Q4 '25: -0.02 Q1 '26: -0.01 Q2 '26: -0.04 Q3 '26: -0.03 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.